First FDA-Approved Hypersomnia Drug Data Published

Lower-sodium oxybate improves idiopathic hypersomnia symptoms and might be a useful first-line therapy or monotherapy or used in combination with alerting agents, newly published data show.

Related Keywords

Georgia ,United States ,France ,Emory University School Of Medicine ,Atlanta ,Lynn Marie Trotti ,Yves Dauvilliers ,Department Of Neurology ,Wake Disorders Center ,Jazz Pharmaceuticals ,Drug Administration ,Epworth Sleepiness Scale ,Gui De Chauliac Hospital ,Cautionary Notes ,Marie Trotti ,Sleep Center ,Emory University School ,Sleep Disorder ,Select Sleep Disorders ,Narcolepsy ,Cataplexy ,Insomnia ,Idiopathic Hypersomnia ,Excessive Daytime Sleepiness ,Obstructive Sleep Apnea ,Sleep ,Hypersomnia ,